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Background: The transcription factor hASH1, encoded by the ASCL1 gene, has a crucial function in neurogenesis and
tumor formation.
Results: Gene expression of ASCL1 is controlled by the RNA-binding protein hnRNP-A2/B1 in neuroblastoma cells grown at
low oxygen tension.
Conclusion: ASCL1mRNA is a new target of hnRNP-A2/B1.
Significance: These findings provide novel insights in oxygen-dependent gene regulatory mechanisms in neuroblastoma cells.
The basic helix-loop-helix transcription factor hASH1,
encoded by the ASCL1 gene, plays an important role in neuro-
genesis and tumor development. Recent findings indicate that
local oxygen tension is a critical determinant for the progression
of neuroblastomas. Here we investigated the molecular mecha-
nisms underlying the oxygen-dependent expression of hASH1
in neuroblastoma cells. Exposure of human neuroblastoma-de-
rived Kelly cells to 1%O2 significantly decreased ASCL1mRNA
and hASH1 protein levels. Using reporter gene assays, we show
that the response of hASH1 to hypoxia is mediated mainly by
post-transcriptional inhibition via the ASCL1 mRNA 5- and
3-UTRs, whereas additional inhibition of the ASCL1 promoter
was observed under prolonged hypoxia. By RNA pulldown
experiments followed by MALDI/TOF-MS analysis, we identi-
fied heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1
and hnRNP-R as interactors binding directly to the ASCL1
mRNA 5- and 3-UTRs and influencing its expression. We fur-
ther demonstrate that hnRNP-A2/B1 is a key positive regulator
of ASCL1, findings that were also confirmed by analysis of a
large compilation of gene expression data. Our data suggest that
a prominent down-regulation of hnRNP-A2/B1 during hypoxia
is associated with the post-transcriptional suppression of
hASH1 synthesis. This novel post-transcriptional mechanism
for regulating hASH1 levels will have important implications in
neural cell fate development and disease.
The formation of neurons in the vertebrate central nervous
system is a multistep procedure, which is initiated by the com-
mitment of progenitor cells to their neuronal fate during the
last mitotic division (1). Soon after exiting from the cell cycle,
destined neural stem cells migrate out of the progenitor zone,
begin to differentiate, and finally acquire a specific neuronal
subtype identity (2). The complex neurogenic differentiation
program is coordinated by basic helix-loop-helix (bHLH)2 tran-
scription factors that are expressed in proliferating progenitor
cells (3, 4). Among them, the repressor-type bHLH genesHes1,
Hes3, and Hes5 are considered to maintain neuronal stem cells
in a proliferative state by antagonizing pro-differentiating
bHLH molecules (5).
The human achaete-scute homolog-1 (hASH1) belongs to a
group of proneural bHLH transcription factors, which directly
control the neurogenic program (6). Human ASH1 (known as
Mash1 in rodents) is encoded by the ASCL1 gene and activates
transcription by binding to the E-box consensusmotif (7). Can-
didate target genes of hASH1 in the developing ventral telen-
cephalon mostly encode transcription factors, signal transduc-
tion components, and structural proteins (8). Functional
annotation by gene ontology suggested a role of hASH1 during
various phases of neurogenesis including cell proliferation,
neuronal cell fate decision, and neurite outgrowth (9).
Targeted gene inactivation in mice demonstrated that
Mash1 is necessary for the differentiation of autonomic neu-
rons and for neural progenitor cell development, particularly in
the ventral telencephalon and in the olfactory epithelium (10–
13). Consistent with the phenotype abnormalities of the null-
mutant mice, Mash1 is temporally and spatially expressed in
the peripheral and central nervous systemofwild-type embryos
(14–16). Although hASH1 was barely detectable in adult tis-
sues, high expression levels were found in neuroendocrine
tumors including small lung cell cancer (17) and neuroblas-
toma (18).
Neuroblastoma is a malignant childhood tumor, which orig-
inates from the sympathetic cell lineage of the neural crest (19).
* This work was supported by Deutsche Forschungsgemeinschaft Grant
FA845/2-2 (to M. F.) and the Bundesministerium für Bildung und Forsc-
hung BMBF ERA-Net NEURON II project CIPRESS (to J. C. M.).
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Notably, patients with high expression of hASH1 in these
tumors had significantly lower survival rates than those with
low expression (20). Themechanistic reason for the association
of high levels of hASH1 in neuroblastomas with poor clinical
outcome is unknown. Mash1/hASH1 has recently been
reported to up-regulate genes that promote cell cycle progres-
sion in neural progenitors (8, 21). It is therefore tempting to
speculate that hASH1 enhances tumor growth by activating
proliferation genes in neuroblastoma cells.
Interestingly, exposure of neuroblastoma-derived cell lines
to a hypoxic atmosphere significantly reduced Mash1/hASH1
and other marker proteins of the sympathetic cell lineage (22,
23). Thus, ASCL1 gene expression in neuroblastoma cells
appears to be regulated by the local tissue oxygenation, which
mayprovide a critical link to tumor formation.However, little is
known about the molecular mechanisms underlying oxygen-
dependent control of ASCL1 gene expression.
We and others have previously shown that theASCL1 gene is
tightly regulated at both the transcriptional and post-transcrip-
tional levels. For example, bHLH factor HES-1 strongly
repressed the ASCL1 promoter in response to activation of the
Notch signaling pathway in neuroblastoma cells (6, 24). Addi-
tionally, Notch signaling may regulate cellular hASH1 homeo-
stasis also by inducing rapid protein degradation (25). On the
other hand, the orphan nuclear receptor TLX, which has a role
in self-renewal of neural stem cells (26) stimulated the pro-
moter of the ASCL1 gene in hippocampus-derived progenitor
cells (27). Post-transcriptionalmechanisms ofASCL1 gene reg-
ulation include a decrease in mRNA half-life, which became
evident after phorbol ester treatment of neuroblastoma cells
and an increase in protein translation, which was mediated by
the fragile X mental retardation protein (FMRP) (28, 29). How
these complex mechanisms interact in control of the cellular
hASH1 protein levels in prolonged hypoxia is not understood.
In view of this background, our study was aimed at elucidat-
ing the molecular signaling pathways responsible for oxygen-
dependent expression of the ASCL1 gene in neuroblastoma
cells. We report here that hypoxia strongly reduces the hASH1
protein in both primary neurons and neuroblastoma cells. Sup-
pression of hASH1 protein synthesis in response to oxygen
restriction is mediated by post-transcriptional control very
early on and in addition by inhibition of the ASCL1 promoter
activity in prolonged hypoxia. Post-transcriptional effects are
mediated by a complex interplay of RNA-binding proteins
hnRNP-A2/B1 and hnRNP-R that act at the 5- and 3-UTRs of
theASCL1mRNA. In fact, hypoxic down-regulation of hnRNP-
A2/B1 seems to be the main influence causing suppression of
hASH1 synthesis during hypoxia.
EXPERIMENTAL PROCEDURES
Cell Culture and RNA/Protein Isolation—Human neuroblas-
toma-derived Kelly cells were grown at 37 °C, 5% CO2 in RPMI
medium supplemented with 10% FBS. For hypoxic measure-
ments, cells were maintained in a hypoxic chamber (1% O2,
37 °C, 5% CO2) for the indicated times. For cytoplasmic extract
preparation, cells were lysed in 20mMTris (pH 7.4) buffer con-
taining 140 mM NaCl, 1 mM EDTA, 0.1% SDS, 0.5% Nonidet
P-40, 25% glucose, 100 units/ml of RNaseOUT (Invitrogen), 1
mM DTT, complete protease-inhibitor mixture (Roche Diag-
nostics), and phosphatase inhibitor mixtures 2 and 3 (Sigma).
After a 10-min incubation on ice, cells were centrifuged at
10,000  g at 4 °C for 10 min to obtain the S10 supernatant.
Total cellular extracts were prepared by direct lysis of cells in 50
mM Tris (pH 6.8) buffer containing 4 M urea and 1% SDS. Total
RNA was prepared using RNA-Bee (Biozol Diagnostica Ver-
trieb GmbH) according to the manufacturer’s protocol. For
RNA measurements after plasmid transfections, the RNA was
first treated with DNase I and the RNA was isolated using the
RNeasy mini kit (Qiagen).
Cell Cultures of Primary Cortex Neurons—Cell cultures of
primary cortex neurons were prepared using E19Wistar rats as
described (30, 31) and according to the permit given by the
Office for Health Protection and Technical Safety of the
regional government of Berlin (LaGeSo, 0122/07). The initial
cell density of cortex cells fromE19Wistar ratswas 68,000/cm2.
Cultured cells were maintained for 1 or 2 days in vitro under
normoxic conditions (ambientO2) in B27- and 1% FCS-supple-
mentedNeurobasalmedium (32). After 1 or 2 days in vitro, cells
were kept for 6 h under hypoxic (0.5%) conditions before they
were fixed using paraformaldehyde and processed for immuno-
chemistry as described (28, 29). The Mash1 antibody was used
at a dilution of 1:500, and the MAP2 antibody at a dilution of
1:300. To visualize cell nuclei, stained preparations were
mounted in 4,6-diamidino-2-phenylindole (DAPI)-containing
Vectashield medium (Vector Laboratories, Burlingame, CA).
Labeled neurons were visualized with a standard epifluores-
cence microscope (Olympus BX51, Olympus Deutschland
GmbH, Hamburg, Germany) under U Plan FL N 10.0 objec-
tive (Olympus). Appropriate filters (U-MSP100v2 MFISH
DAPI and U-MSP102v1 MFISH Cy3; Olympus GmbH, Ger-
many) allowed the detection and separation of fluorescent sig-
nals. Images were acquired and processed using a 14-bit cooled
CCD camera (Spot PURSUIT, Visitron Systems GmbH, Puch-
heim, Germany) and using software Metamorph (Universal
Imaging Corp., Downingtown, PA). Statistical significance was
assessed using one-way analysis of variance followed by a post
hoc Bonferroni test.
RNA Pulldown Assays—Biotin-labeled RNA was prepared
from a PCR amplicon using the M13 forward sense primer and
an ASCL1 mRNA-specific reverse primer. The amplicon con-
tained the T7 promoter sequence and either the 5-UTR or the
3-UTR of ASCL1mRNA. The PCR products were transcribed
in vitro using recombinant T7 polymerase. Biotin-labeled
RNAs were produced according to the suggestions of the man-
ufacturer (Promega) with the modification that biotin-16-UTP
(Roche Diagnostics) was included in a 3:1 ratio with UTP.
Labeled RNAs were precipitated with LiCl and ethanol, and
resuspended in diethyl pyrocarbonate water. The concentra-
tions of the biotin-labeled RNAs were determined by absor-
bance at 260 nm.
For UV cross-linking experiments, 1 g of RNA/mg of
extract was used. The in vitro transcribed RNA was first incu-
bated with extract for 20 min at room temperature with gentle
rotation to allow binding to occur. Cross-linking was per-
formed in 50-l aliquots in a single well of a 96-well plate using
the auto cross-link setting (120,000 J) (Stratagene,
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UV-Stratalinker 1800). Samples were then pooled and RNA
pulldown was carried out using Streptavidin-agarose affinity
beads (Sigma). Beads were washed extensively in wash buffer
(20 mM Tris, pH 7.4, 3 mM MgCl2, 250 mM KCl, 0.5 mM DTT)
with a final wash step in wash buffer containing 150 mM KCl.
After the final wash step, the bound proteins were eluted by
treatment with 10 g/ml of RNase A and 10 units/ml of RNase
T1 inwash buffer containing 150mMKCl and 1mMEDTA.The
proteinswere precipitated using 100%TCAand resuspended in
SDS-PAGE loading buffer forWestern blot analysis or submit-
ted directly for MALDI-TOF mass spectrometry analysis as
previously described (33).
Antibodies—The antibodies used were mouse monoclonal
anti-Mash1 (BD Pharmingen), mouse monoclonal anti-hn-
RNP-A2/B1 (Acris Antibodies), mouse monoclonal anti-
nucleolin (Santa Cruz Biotechnology), rabbit polyclonal anti-
hnRNP-R (Abcam), rabbit polyclonal anti-PABP2 (Abcam),
rabbit polyclonal anti-Tubb2B (Proteintech), rabbit poly-
clonal anti-hnRNP-K (Novus Biologicals), and guinea pig
polyclonal anti-MAP2 (Synaptic Systems). Secondary anti-
bodies used were donkey anti-rabbit IgG-HRP and goat anti-
mouse IgG-HRP (Santa Cruz Biotechnology). Secondary
antibodies coupled to carboxymethyl indocyanine or fluo-
rescein isothiocyanate were used for immunofluorescence
(Jackson ImmunoResearch Laboratories).
RNAQuantification by qPCR—Random hexamers were used
to generate cDNA from 1 g of total RNA using the High
Capacity cDNA Reverse Transcription kit (Applied Biosys-
tems). Quantitative real-time PCR (qPCR) experiments were
carried out on an Applied Biosystems GeneAmp 5700 system
using SYBRGreenmastermixture according to themanufactu-
rer’s instructions. Each samplewasmeasured in triplicate.mRNA
expression levels were normalized to 18 S rRNA using the Ct
method.The following primer sequenceswere used: 18 S forward,
5-GATCAAAACCAACCCGGTCA, 18 S reverse, 5-CCGTTT-
CTCAGGCTCCCTCT; hASH1 forward, 5-CGACTTCACCA-
ACTGGTTCT, hASH1 reverse, 5-CCGTGAATGATTGGAG-
TGC; hnRNP R forward, 5-GCCCCTTTTTGAGAAGGCCG,
hnRNP R reverse, 5-ACGTCCACCAAACCCTCTGT; hnRNP
A2/B1 forward, 5-GTTATGGAGGAGGAAGAGGA, hnRNP
A2/B1 reverse, 5-CGTAGTTAGAAGGTTGCTGG; and Firefly
luciferase forward, 5-TCAAAGAGGCGAACTGTGTG, Firefly
luciferase reverse, 5-GGTGTTGGAGCAAGATGGAT.
RNA Interference—Transfection of control siRNA and
siRNA targeted against hnRNP-R, hnRNP-A2/B1, and PABP2
into Kelly cells was performed using SilenceMag (OZ Biosci-
ences) or DharmaFECT 2 (Thermo Scientific) as specified by
the manufacturers. All siRNAs were purchased as SMARTpool
siRNAs from Thermo Scientific Dharmacon. Cells were har-
vested 24 and 48 h post-transfection. For hypoxia treatment,
48 h post-transfection, one set of transfected cells was incu-
bated at normoxia (21% O2) and one set was subjected to 24 h
hypoxia (1% O2) prior to analysis.
Cell Transfections and Reporter Gene Assays—Reporter con-
structs bearing the ASCL1 promoter or ASCL1 mRNA UTRs
(including the followingmutants: U-rich (nucleotide 223–232),
GA-rich element (nucleotide 304–330), and AU-rich element
(nucleotide 397–416)) have been previously described (28).
Each plasmid along with the Renilla luciferase phRL-TK vector
(Promega) were co-transfected into 70% confluent Kelly cells
grown in 96-well plates using Roti-Fect (Carl-Roth GmbH &
Co.). After an overnight incubation, the medium was changed.
Cells were grown for an additional time at normoxia (21% O2;
control) or hypoxia (1%O2) as indicated. For overexpression of
hnRNP-B1 a commercially available expression vector was
used (pReceiver-M02 vector, GeneCopoeiaTM, Inc., Ex F0171-
M02) as described earlier (34). Luciferase activitywasmeasured
using theDual-GloTM luciferase assay system and the datawere
collected using a luminometer (Labsystems Luminoskan RS).
Prediction of RNA-Protein Interaction—The online tool
catRAPID fragments module (35, 36) was used to predict a
putative hnRNP-A2/B1 binding site within the ASCL1 mRNA
5-UTR. Accession numbers for hnRNP-A2/B1 and ASCL1 are
ENST00000354667 and ENST00000266744, respectively.
mRNA Level Correlation Study—Normalized human mRNA
expression levels for HNRNPA2B1, HNRNPR, and ASCL1
mRNAs were obtained from the Stanford Microarray database
(37) as described by Stuart et al. (38). This set contains 12,435
gene entries that match to ENSEMBL genes and 1202 microar-
ray experiments in total. The difference of the sum of all
microarrays in the database and the number of data points used
for the correlation analysis in this study results from the fact
that some entries for correlated candidates were missing in the
microarray data sets. Regression and correlation analysis was
performed using themathmodule of the open source/GPLpro-
gram xmgrace based onGrace-5.1.22 in the linux environment.
Statistics—If not indicated otherwise, all values are presented
as mean  S.D. Student’s paired t test was applied to reveal
statistical significances. p 0.05 was considered significant.
RESULTS
Oxygen Deprivation Suppresses Mash1/hASH1 Expression—
To explore whether expression of the rodent Ascl1 homolog
Mash1 is sensitive to the local oxygen concentration, cortical
neuronswere isolated from rat embryos (E19) and kept either at
21 or 0.5%O2. CellularMash1 protein was visualized by immu-
nofluorescence, and the integrated signal intensity was deter-
mined within nucleus-centered circular regions of interest, as
described earlier (28, 39).Hypoxia diminishedMash1 immuno-
reactivity in primary cortical neurons in vitro (Fig. 1). Consis-
tently, expression of the human ASCL1 gene in the Kelly neu-
roblastoma cell line was also significantly reduced in hypoxia
(Fig. 2). In a time course up to 48 h of hypoxia, we observed a
fast and persistent drop in ASCL1mRNA (Fig. 2a) and protein
levels (Fig. 2, b and c) thatwas detected as early as 3 h of hypoxia.
Although the reduced ASCL1mRNA level remained relatively
stable at 40% compared with control conditions, the hASH1
protein level showed a much stronger decrease following 12 h
of hypoxia (20% compared control). This stronger influence
at the protein level could be attributed to the global suppression
of mRNA translation during hypoxia (40). In line with this,
protein stabilitymeasurements indicated no change in the half-
life of hASH1 in hypoxia (data not shown).
Regulation of ASCL1/hASH1 Expression during Hypoxia—
Gene expression regulated at the transcriptional level is pri-
marilymediated by changes in promoter activity, whereas at the
hASH1 Suppression by hnRNP-A2/B1 in Hypoxia
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post-transcriptional level, for e.g. by alterations in mRNA sta-
bility, localization and/or translational efficiency, is mainly
mediated by themRNA5- and 3-UTRs. To identify themech-
anisms, whether transcriptional or post-transcriptional, regu-
lating ASCL1/hASH1 expression during hypoxia, we per-
formed reporter gene assays using either the ASCL1 promoter
construct or constructs containing either or both the ASCL1
mRNA5- and 3-UTRs. A schematic diagramof the constructs
is shown in Fig. 3a. The constructs were transfected into Kelly
cells and exposed to hypoxia for the indicated times.
At early time points (3 and 6 h of hypoxia), we observed a
weak but significant decrease in ASCL1 promoter activity
(70% compared with control) and a similar inhibition via the
ASCL1mRNA UTRs (75% compared with control) (Fig. 3, b
and c). Strikingly, at 12 and 24 h of hypoxia, repression of
ASCL1/hASH1 expression could be attributed only to the
UTRs that showed an almost 50% decrease of UTR-dependent
luciferase reporter activity (Fig. 3, b and c). At 48 h of hypoxia,
both the ASCL1 promoter and mRNA UTRs resulted in
decreased luciferase activity. We further determined the indi-
vidual contributions of theASCL1mRNA5- and 3-UTRs (Fig.
3, d and e). Although we observed that hypoxic inhibition is
mediated by both the ASCL1mRNA 5- and 3-UTRs, our data
suggest a stronger influence of the 5-UTR.
To ensure that these differences in luciferase activity directly
reflect luciferase mRNA levels, we performed qPCR analysis to
determine luciferase mRNA levels. In contrast to the promoter
luciferase activity data (Fig. 3a), no significant alterations at the
mRNA level were observed at early time points (Fig. 3f). How-
ever, we observed a weak but significant increase in the lucifer-
ase mRNA level after 24 h of hypoxia followed by a decrease at
48 h that was mediated by the ASCL1 promoter (Fig. 3f). These
findings indicate that under prolonged hypoxic conditions
transcriptional control also contributes to the inhibition of
hASH1 synthesis. It is evident that for theASCL1mRNAUTRs
the decrease in luciferase activity is in agreement with its lucif-
erase mRNA level (Fig. 3g). Taken together, our findings sug-
gest a repression of the ASCL1 promoter activity under
prolonged hypoxic conditions, with a continuous level of
repression provided by post-transcriptional mechanisms.
Trans-acting Factors Interacting with ASCL1mRNAUTRs in
Kelly Neuroblastoma Cells—We chose 24 h of hypoxia as the
time for all future experiments to focus primarily on post-tran-
scriptional mechanisms of ASCL1/hASH1 regulation.
Post-transcriptional control is mediated by trans-acting fac-
tors, such as RNA-binding proteins (RBPs) or micro-RNAs
(miRNAs) that recognize cis-elements in the respective tran-
script. To identify RBPs that bind to theASCL1mRNAUTRs in
neuroblastoma cells, we performed biotinylated RNA-strepta-
vidin-based pulldown assays after UV cross-linking, and iso-
lated RBPs bound directly to either the 5- or 3-UTRs from
cytosolic extracts of cells cultivated either at 21 or 1% O2. Here
it is important to note that the 3-UTR construct lacked a
poly(A) tail. A representative silver-stained gel of the isolated
proteins is shown in Fig. 4a. We observed qualitative differ-
ences between factors binding at the 5- and 3-UTRs with sub-
tle differences during hypoxia. Protein eluates were collected,
subjected to MALDI/TOF-MS analysis, and compared with
samples from the control pulldown. Identified factors bound
either to the 5- and/or the 3-UTR and not to a control pull-
down are shown in Table 1. We selected nucleolin, hnRNP-R,
hnRNP-A2/B1, and PABP2 (PABPN1) for further verification
by Western blot analysis, as they were identified by a good hit
quality and are well known RBPs (Fig. 4b).
Nucleolin was found to interact with both the 5- and the
3-UTRs. However, nucleolin showed neither an alteration at
the protein level in hypoxia nor a consistent change in its bind-
ing behavior, and thus was not considered for detailed func-
tional analysis (Fig. 4b). The RBP hnRNP-R indicated a weaker
binding at the ASCL1 mRNA 5-UTR following hypoxia, in
favor of an increased binding at the 3-UTR (Fig. 4b). The cyto-
plasmic hnRNP-R protein level was not significantly changed
during hypoxia (Fig. 4b). PABP2 preferentially interacted with
the ASCL1 mRNA 3-UTR. We observed no changes of the
cytoplasmic protein level in hypoxia or of its binding ability
FIGURE 1.Hypoxia reducesMash1 protein levels in primary cortical neurons. a and b, representative images in the top panels show signals corresponding
to DAPI (green) and the neuronal marker MAP2 (red) in primary cortical neurons kept under control (21% O2) (a) and hypoxic (0.5% O2) (b) conditions.
Correspondingminimum/maximum thresholdedMash1 signals are shown in the bottompanels. c, quantitation of the integratedMash1 signal intensities (a.u.,
arbitrary units)measured in the circular regionsof interest (dotted circles in thebottompanels a andb) projectedon thenuclei ofMAP2-positiveneurons. Values
shown aremean S.E. The numbers in parentheses indicate the total number of investigated neurons under each condition from three different cell cultures.
1 or 2 1 or 2 day(s) in vitro (d.i.v.); C, control; Hy, hypoxia. Significant differences are indicated with asterisks (***, p 0.001).
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(Fig. 4b). In contrast, the level of cytoplasmic hnRNP-A2/B1
protein was reduced in hypoxia, whereas the binding to the
5-UTR was maintained (Fig. 4b). It is of interest that although
the A2 isoform is more prominently expressed, it is the B1 var-
iant that exhibited a higher RNA binding capacity. We con-
firmed that hnRNP-A2/B1 preferentially interacted with the
FIGURE 2.Hypoxia causes a time-dependent decrease inASCL1mRNAand hASH1 protein levels in Kelly neuroblastoma cells. a, Kelly cells were grown
under control (21%O2, C) or hypoxic (1%O2, Hy) conditions for up to 48 h as indicated. The ASCL1mRNA level was determined by qPCR and shows a constant
decline duringhypoxia (black bars) relative to control (gray bars).b,Westernblot analysiswas performed to assess relative hASH1protein levels. Tubulin served
as a loading control. c, quantitation and statistical analysis of the Western blot results (n 6; *, p 0.05; **, p 0.01; ***, p 0.001).
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ASCL1 mRNA 5-UTR, which was identified to mediate a
stronger influence in post-transcriptional inhibition of hASH1
synthesis in hypoxia (Fig. 3).
To test the functional relevance of the selected RBPs on
hASH1 synthesis, we silenced each RBP expression by
siRNA-mediated transient knockdown in Kelly cells. We first
performed the knockdown for 24 and 48 h under control con-
ditions and correlated the level of RBP knockdown with altera-
tion in the hASH1 protein level for each sample (Fig. 5). We
found a highly significant positive correlation between hASH1
and hnRNP-A2/B1 (Fig. 5, a and b) as well as between hASH1
and hnRNP-R expression levels (Fig. 5, c and d). In contrast,
hASH1 protein levels did not correlate with PABP2 (Fig. 5, e
and f). Although this suggests that PABP2 does not play a role in
regulating hASH1 levels under these conditions, the lack of
effect might also be explained by the fact that PABP4 and
PABP5 can compensate for the function of PABP2 (41).
Role of hnRNP-A2/B1 and hnRNP-R in Inhibition of ASCL1/
hASH1 Expression during Hypoxia—As we identified hnRNP-
A2/B1 and hnRNP-R to correlate with hASH1 protein levels in
neuroblastoma cells at 21%O2,we askedwhether one or both of
these RBPs mediate post-transcriptional control in hypoxia.
We, thus, first silenced hnRNP-A2/B1 and hnRNP-R levels in
Kelly cells for 48 h and then exposed the cells to 21 (control) or
FIGURE 3. Transcriptional and post-transcriptional regulation of ASCL1 mRNA in hypoxia. Kelly cells were transfected with firefly-reporter constructs
containingeither theASCL1promoter or theASCL1mRNA5- and/or 3-UTRand incubatedunder control (C, 21%O2) or hypoxic (Hy, 1%O2) conditions for up to48h.
Valueswerenormalized toRenillaactivityandpresented relative to thepGL3-promotervector (SV40promoter).a, schematicof theconstructsused.b, influenceof the
ASCL1promoteron luciferaseactivity inhypoxia. c-e, luciferaseactivity in thepresenceofboth theASCL1mRNA5- and3-UTRs (c) and the individual influencesof the
ASCL1mRNA5-UTR (d) and3-UTR (e) in hypoxia (n6; *,p0.05; **,p0.01; ***,p0.001). f andg,qPCRanalysis todetermine luciferasemRNA levels controlled
either by the ASCL1 promoter (f) or ASCL1mRNA5- and 3-UTRs (g) under control and hypoxic conditions (n 3; ***, p 0.001).
FIGURE 4.Affinity chromatography identificationof RBPs interactingwith theASCL1mRNAUTRs. Kelly neuroblastoma cellswere subjected to control or
hypoxic conditions for 24h. Cellular extractswerepreparedandused for affinity chromatographywith in vitro transcribedbiotinylated transcripts representing
theASCL1mRNA5- or 3-UTRasbait.a, representative silver-stainedgel of the capturedproteins binding to either theASCL1mRNA5- or 3-UTRunder control
or hypoxic conditions. A no-transcript sample served as a negative control (beads only). b,Western blot confirmation of the trans-acting factors identified by
MALDI/TOF-MS analysis (see Table 1). Cellular extracts that were used for affinity chromatography are shown in the input lanes. hnRNP-K and tubulin served as
negative controls.
TABLE 1
List of ASCL1 5- and 3-UTR interacting proteins identified bymass spectrometry
Proteins were identified byMALDI-TOF/MS analysis. Gene symbols corresponding to the identified candidates are given on the right side. Candidates identified with high
confidence and being known RNA-binding proteins are marked in bold.
Gene symbol
5-UTR
Histone H3.2 HIST2H3A
Nucleolin NCL
Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein,  YWHAZ
Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein,  YWHAB
Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific NSD1
Y box binding proteins-1, -2, -3 YBX1, -2, -3
Heterogeneous nuclear ribonucleoproteins-A2/B1 HNRNPA2B1
Heterogeneous nuclear ribonucleoprotein-R HNRNPR
RNA binding motif protein, X-linked-like 1 RBMXL1
Apolipoprotein A-I APOA1
Complement component 1, q subcomponent binding protein C1QBP
U2 small nuclear RNA auxiliary factor 2 U2AF2
Serine/arginine-rich splicing factor 3 SRSF3
Histone cluster 1, H2ab HIST1H2AB
Microtubule-associated protein 2 MAP2
3-UTR
Heterogeneous nuclear ribonucleoprotein R HNRNPR
Poly(A)-binding protein, nuclear 1 (PABP2) PABPN1
Microtubule-associated protein 2 MAP2
Nucleolin NCL
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FIGURE 5. hASH1 protein levels correlate with hnRNP-A2/B1 and hnRNP-R in Kelly cells. siRNA-mediated knockdown of hnRNP-A2/B1, hnRNP-R, and
PABP2 was carried out in Kelly cells under control conditions. Cells were harvested following 24 and 48 h of siRNA transfection and subjected toWestern blot
analysis.a, c, and e, representativeWesternblot results and correlation analysis after hnRNP-A2/B1 (a andb), hnRNP-R (c andd), andPABP2 (e and f) knockdown.
The blots were probed for hASH1 and the respective antibody. Tubulin served as a loading control. For the correlation analysis all values were normalized to
tubulin. The regression lines, correlation coefficients, and p values are shown.
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1% (hypoxia)O2 for an additional 24 h.We then quantitated the
mRNA levels of ASCL1 and both RBPs by qPCR (Fig. 6). Tran-
sient knockdown of hnRNP-A2/B1 caused a striking drop in
steady-state ASCL1mRNA levels to 53% under control condi-
tions (Fig. 6a). hnRNP-R had a lesser but also significant effect
on ASCL1 mRNA levels under control conditions (Fig. 6a).
Hypoxia consistently caused a decrease inASCL1mRNA levels
during control knockdown conditions. This level of decrease
was maintained by the RBP knockdowns in hypoxia despite the
already lowered levels of ASCL1mRNA in these cells (Fig. 6a).
Knockdown efficiency was confirmed by measurement of
HNRNPA2B1 (Fig. 6b) and HNRNPR (Fig. 6c) mRNA levels.
Interestingly, mRNA levels of both RBPs were significantly
reduced during hypoxia in the presence of non-targeting
siRNA. Of note is that the hnRNP-R knockdown caused a sig-
nificant decrease in HNRNPA2B1 mRNA levels (Fig. 6b), and
the hnRNP-A2/B1 knockdown resulted in a corresponding
reduction of HNRNPR mRNA levels (Fig. 6c). These observa-
tions indicate that both hnRNP-A2/B1 and hnRNP-R not only
influence hASH1 expression, but also mutually control the
expression of each other.
We further verified our observations at the protein level by
Western blot analysis (Fig. 7). Consistent with the effect of the
ASCL1 mRNA level, hnRNP-A2/B1 knockdown caused an
50% reduction in hASH1 protein levels (Fig. 7, a and c, left
panels). Furthermore, in addition to hASH1, hnRNP-A2/B1
protein levels were also reduced by hypoxia, as observed in
Kelly cells that were transfectedwith non-targeting siRNA (Fig.
7, a and b, left panels). hnRNP-R showed a weaker but signifi-
cant effect on hASH1protein levels, consistentwith its effect on
ASCL1mRNA levels (Fig. 7, a and c, middle panels). We would
like to point out that, in contrast to its mRNA level, hnRNP-R
protein showed no significant decrease in hypoxia (Fig. 7, a and
b,middle panels).We speculate that the hnRNP-R protein half-
life is very high and thus would show a delayed response that is
not observed under these conditions. Nevertheless, hASH1 lev-
els were nearly non-detectable in hypoxia following hnRNP-
A2/B1 or hnRNP-R knockdown. In the case of hnRNP-R
knockdown, our data indicate a much stronger decrease of
hASH1 at the protein level in hypoxia, suggesting that
hnRNP-R delays the suppressive hypoxic influence on hASH1
synthesis.
PABP2 knockdown had no effect on the ASCL1mRNA level
(data not shown) or at the protein level during control or during
hypoxic conditions (Fig. 7, a and c, right panels). Taken
together, these data show that hnRNP-A2/B1 knockdown
causes a strong decrease inASCL1/hASH1 levels that is further
enhanced in hypoxia. It appears that the main effect on hASH1
synthesis under hypoxic conditions is due to the reduced
expression of hnRNP-A2/B1 that directly affectsASCL1mRNA
and hASH1 protein levels. These data are in line with the
observed time course ofASCL1/hASH1 suppression in hypoxia
that indicated a strong post-transcriptional influence following
12 h or longer of hypoxia, highlighting the need first for the
down-regulation of hnRNP-A2/B1.
Forced Expression of hnRNP-B1 Prevents hASH1 Suppression
in Hypoxia—The data described above pointed to a key role of
hnRNP-A2/B1 in regulating hASH1. The RNA pulldown
FIGURE6.hnRNP-A2/B1affectssteadystate levelsofASCL1mRNA.Kellyneu-
roblastoma cellswere transfectedwith either control siRNA (si-control) or siRNAs
silencing the HNRNPA2B1 (si-hnRNP-A2/B1) or HNRNPR (si-hnRNP-R) genes and
grown for 48 h. Cells were further cultivated for an additional 24 h under control
(21% O2, gray bars) or hypoxic (1% O2, black bars) conditions. ASCL1 (a),
HNRNPA2B1 (b), and HNRNPR (c) mRNA levels after control and specific knock-
down conditions. Asterisks indicate significant differences between control and
hypoxia for specific siRNA treatment. Number signs indicate a significant altera-
tionbyRBPknockdowncomparedwithcontrol si-RNA(n6; */#,p0.05; **/##,
p 0.01; ***/###, p 0.001).
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experiments indicated a preferential binding of hnRNP-B1 to
the ASCL1 mRNA 5-UTR (Fig. 4b). We, therefore, separately
quantified the decrease of hnRNP-A2 and -B1 byWestern blot
analysis following 24 h of hypoxia (Fig. 8a). The data revealed a
stronger decrease of the B1 form, with hnRNP-B1 levels drop-
ping to 38% and hnRNP-A2 to 75% comparedwith control con-
ditions. We then focused on the mechanism by which a
decrease in hnRNP-A2/B1 could influence hASH1 synthesis.
Because steady-state measurements showed a decrease in
ASCL1 mRNA levels under hnRNP-A2/B1 knockdown condi-
tions (Fig. 6a), we wanted to examine whether ASCL1 mRNA
stability is altered. To do this, cells were treated with actinomy-
cin D for up to 4 h after silencing of hnRNP-A2/B1. Quantita-
tion of ASCL1 mRNA levels showed an 30% decrease in
ASCL1mRNA stability (Fig. 8b). This finding supports the view
that hnRNP-A2/B1 is a modulator of ASCL1mRNA stability.
We next aimed to identify the hnRNP-A2/B1 binding site
within the ASCL1 mRNA 5-UTR. By using the online tool
catRAPID fragments module (35, 36), a GA-rich element
(nucleotide 276–335) was predicted as a putative hnRNP-
A2/B1 interaction site. To focus only on theGA-rich region, we
deleted 25 nucleotides within the predicted binding site (del
GA-rich). We also created deletion constructs in one upstream
(del U-rich) and one downstream (del_AU-rich) element (Fig.
8c). Using these constructs in RNA pulldown experiments, we
found thatmutation of theGA-rich element prevented hnRNP-
FIGURE 7. hnRNP-A2/B1 affects steady state levels of hASH1 protein. Kelly neuroblastoma cells were transfected with either control siRNA (si-control) or
siRNAs silencing the HNRNPA2B1 (si-A2/B1), HNRNPR (si-R), or PABP2 (si-PABP2) genes and grown for 48 h. Cells were further cultivated for an additional 24 h
under control (21%O2) or hypoxic conditions (1%O2). a, representativeWestern blot results for hASH1 and hnRNP-A2/B1 (left panel), hnRNP-R (middle panel),
and PABP2 (right panel) following specific knockdown, respectively. Tubulin served as a loading control. b and c, statistical analysis of theWestern blot results
following knockdown of hnRNP-A2/B1, left; hnRNP-R,middle; and PABP2, right panel, are shown in b and the corresponding hASH1 protein levels in c.Number
signs indicate a significant alterationbetween control andhypoxia.Asterisks indicate significant changesbyRBP knockdowncomparedwith control siRNA (n
6; */#, p 0.05; **/##, p 0.01; ***/###, p 0.001).
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A2/B1 binding to the ASCL1 mRNA 5-UTR (Fig. 8d). Func-
tional verification using these constructs by reporter gene
assays was performed following forced hnRNP-B1 expression
as the hnRNP-B1 variant showed a stronger ASCL1 mRNA
5-UTR binding capacity (Fig. 4b) and its decrease was more
pronounced in hypoxia (Fig. 8a).We observed that overexpres-
sion of hnRNP-B1 had no effect on the ASCL1 promoter (Fig.
8e). Consistentwith the finding that hnRNP-A2/B1 binds to the
ASCL1 mRNA 5-UTR (Fig. 4b), we found the strongest
increase in luciferase activity for the ASCL1 mRNA 5-UTR
containing constructs. Deletion of the GA-rich element and
thus loss of hnRNP-B1 binding abolished the increase in lucif-
erase activity. In contrast, deletion of the other two cis-ele-
ments had no effect on hnRNP-A2/B1-dependent activation of
ASCL1 mRNA 5-UTR dependent luciferase activity (Fig. 8e).
These data confirm that hnRNP-A2/B1 directly binds to the
ASCL1mRNA 5-UTR and activates hASH1 expression.
Finally, we tested whether the decrease of hASH1 synthesis
in hypoxia could be prevented or at least attenuated by forced
expression of hnRNP-B1. Notably, up-regulation of hnRNP-B1
resulted in elevated hASH1 levels under control conditions
(Fig. 8, f and g). Overexpression of hnRNP-B1 strongly attenu-
ated the inhibition of hASH1 synthesis during hypoxia. In par-
ticular, following mock transfection, the hASH1 level declined
to 17% in hypoxia, compared with 70% following forced
hnRNP-B1 expression (Fig. 8g). These observations indicate
that hnRNP-A2/B1, especially the B1 form, is a major determi-
nant of hASH1 expression in hypoxia.
Global Positive Correlation of ASCL1 with HNRNPA2B1—
Finally, we aimed at confirming our findings of hnRNP-A2/B1
and hnRNP-R being trans-acting factors in hASH1 synthesis at
the post-transcriptional level in a broader biological context.
For this purpose, we correlated mRNA levels of ASCL1 as well
as HNRNPA2B1 and HNRNPR using independent experimen-
tal data derived from	1200 microarray experiments available
at the Stanford Microarray database (Fig. 9). Data were used as
described by Stuart et al. (38). The data contain expression pro-
files of different in vitro experiments including studies of
diverse biological processes such as cell cycle, stress, signaling,
and apoptosis. Furthermore, this data collection contains
expression profiles from tumor samples and different organ-
specific tissue samples. A significant correlation can be
expected if both candidates (i) are regulated by the same fac-
tor(s) or (ii) if one candidate is regulating the expression level of
the other. In addition to the significance level (p value) that is
derived from the correlation coefficient, a good correlation is
also indicated by the moving average (red line in Fig. 9, a–d),
which follows the regression line (blue line in Fig. 9, a–d).
Analysis of these large-scale gene expression data confirmed
a positive correlation between HNRNPA2B1 and ASCL1
mRNA levels that is seen by both, a highly significant p value as
well as a good fit of the moving average to the regression line
(Fig. 9a). In linewith our experimental findings, these data indi-
cate a general role of hnRNP-A2/B1 in regulating hASH1
expression. However, the correlation of ASCL1 mRNA and
HNRNPRmRNA showed no significance (Fig. 9b). It is possible
that the effect of hnRNP-R on hASH1 synthesis might be influ-
enced by other factors and is more cell type or context specific.
The effect we observed is also more pronounced at the protein
level and would not be reflected here. As a negative control we
used a correlation between HNRNPK mRNA and ASCL1
mRNA as PABP2 participates in a general regulation of all
mRNAs via its interactionwith the poly(A) tail andwould likely
result in a positive correlation. hnRNP-K was found not to
interact with ASCL1 mRNA UTRs (Fig. 4b), and as expected
showed no correlation (Fig. 9c). Because our data indicated that
hnRNP-A2/B1 and hnRNP-R influence the expression level of
each other, we asked whether this also holds true on a global
scale. The strikingly strong positive correlation using large-
scale gene expression data strongly hints to themutual effect of
hnRNP-A2/B1 and hnRNP-R on each other (Fig. 9d).
DISCUSSION
Oxygen depletion has been reported to cause a decrease in
the expression of several neuronal and neuroendocrine marker
genes including ASCL1/hASH1. Importantly, ASCL1/hASH1
can determine different cell fates by promoting either prolifer-
ation or differentiation of neural progenitors (8, 42). Thus, the
local oxygen concentration may adjust ASCL1/hASH1 expres-
sion and associated pro-neural signaling pathways to the opti-
mum level for the generation of different cell types in the devel-
oping central nervous system. In this study, we show that
ASCL1/hASH1 expression during hypoxia is regulated by both,
transcriptional and post-transcriptional mechanisms. Al-
though transcriptional regulation via the ASCL1 promoter was
observed under prolonged hypoxic conditions only, post-tran-
scriptional control persists throughout and was already detect-
able during the early phase of hypoxia. We identified hnRNP-
A2/B1 as one of the key post-transcriptional modulators of
hASH1 synthesis during hypoxia.
The balance between pro-neural and repressor-type bHLH
transcription factor signaling pathways under hypoxic condi-
tions is crucial for neuronal fate. ASCL1/hASH1 expression
during hypoxia has been attributed to such repressor-type sig-
naling, for example, by Notch1-activated Hes1/5, leading to
down-regulation of the ASCL1 promoter activity (25, 43).
FIGURE 8. Influenceof hnRNP-B1onASCL1/hASH1expression.a, Kelly cellswere grownunder control (21%O2,C) or hypoxic (1%O2,Hy) conditions for 24 h.
Western blot analysis was performed to assess relative hnRNP-A2 and hnRNP-B1 protein levels. Tubulin served as a loading control. Shown is a representative
Western blot and statistical quantification for hnRNP-A2 and -B1 protein levels following 24 h of hypoxia. b, ASCL1 mRNA half-life measurements following
control (si-control) or hnRNP-A2/B1 (si-hnRNP-A2B1) knockdown conditions. c, schematic of the cis-element deletions within the ASCL1 mRNA 5-UTR. The
putative hnRNP-A2/B1 binding site as predicted by the catRAPID fragmentsmodule is indicated. d,Western blot analysis for hnRNP-A2/B1 after RNApulldown
using the ASCL1 mRNA 5-UTR and the mutated variants as indicated in c. hnRNP-A2/B1 binding was severely impaired following deletion of the predicted
binding site. A Coomassie Blue-stainable band served as a loading control. e, reporter gene assays following forced hnRNP-B1 expression. (For a schematic of
constructs used see also Fig. 3a.) Valueswerenormalized toRenilla activity. f, representativeWesternblot analysis following forcedhnRNP-B1expressionunder
control and hypoxic conditions. g, statistical analysis for f. Asterisks indicate significant changes between mock and hnRNP-B1 transfection. Number signs
indicate a significant alteration between control and hypoxia (n 4; ***/###, p 0.001; ##, p 0.01).
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Moreover, increased Hes1/5 activity reduced the number of
primary dendrites and promoted dendrite elongation instead of
dendrite branching (44). These changes will inevitably impair
synaptogenesis as well, because dendrite arborization precedes
synapse formation at the dendritic tree (45, 46). There is a crit-
ical time window for dendrite arborization and synaptogenesis
between the third trimester of pregnancy and the first few years
of postnatal life where changes in the developmental program
will have long-term consequences for neural network integrity
that extends from puberty to adolescence and beyond (45, 47,
48). During the early critical period of neuronal differentiation
changes in hASH1 levels, as occurring in hypoxia, will severely
impact neural network function. Indeed, when neuroblastoma
cells were induced to differentiate, hASH1 levels were rapidly
down-regulated as an integral step to attaining amore differen-
tiated phenotype, although whether constitutive expression of
hASH1 would inhibit differentiation was not clearly resolved
(49).
Among themajor transcriptional effectors ofASCL1, Notch1
signaling was also shown to cause rapid degradation of hASH1
in overexpression studies (25). However, in our study we did
not observe a reduced half-life of hASH1 protein during
hypoxia. Consistent with the effect of HES-1 on ASCL1 regula-
tion, we found a transcriptional inhibitory effect in prolonged
hypoxia via the ASCL1 promoter and a more sustained influ-
ence by the ASCL1 mRNA UTRs during continuous hypoxia.
Activation of Notch1/HES-1 has also been shown in cultured
microglial cells exposed to hypoxia, although the response was
slightly altered in primary cultured microglia (50).
Our data strongly support the view that hASH1 expression in
hypoxia is determined by post-transcriptional control. Our
findings reveal hnRNP-A2/B1 and hnRNP-R as important
molecular determinants of hASH1 expression in hypoxia,
through their direct interaction with theASCL1mRNA 5- and
3-UTRs. This may be relevant for both neuronal cell fate deci-
sion and neuroendocrine tumor formation.
FIGURE 9. HNRNPA2B1mRNA correlates globally with ASCL1mRNA. Large-scale microarray expression data were obtained from the Stanford microarray
database (37). The set contains genome-wide data from 1202 hybridization experiments from human tissues and cell lines. Correlation of HNRNPA2B1 (a),
HNRNPR (b), andHNRNPK (c)mRNA levelswithASCL1mRNA levels.d, correlationbetweenHNRNPA2B1 andHNRNPRmRNAs. Thenumbersofmatchedvalues (n),
coefficient of determination (R2), as well as the significance levels (p) are indicated. The regression line is shown in blue. The moving average is indicated as a
red line and was performed on the x axis sorted values.
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The protein hnRNP-A2/B1 belongs to an RNA-binding pro-
tein family that plays important roles in the control of gene
expression andmRNA processing. It is overexpressed in a vari-
ety of tumors, including breast, lung, and pancreas carcinomas
(51–53). Altered expression of hnRNP-A2/B1 has also been
reported during lung carcinogenesis where hASH1 seems to be
involved (54, 55). Histochemical mapping of hnRNP-A2/B1
suggested a function in post-transcriptional regulation of neu-
rons in the cerebral cortex and hippocampus in response to
ischemia-reperfusion injury (56). Prolonged hypoxia has been
reported to have a pronounced effect on cytoplasmic hnRNP-
A2/B1 levels that is partially dependent on a higher mRNA
turnover under hypoxic conditions (57). Our RNAi experi-
ments under normoxic conditions revealed a significant co-
regulation of hnRNP-A2/B1, hnRNP-R, and hASH1, suggesting
that a complex network of molecular interactions governs
mRNA regulation in response to hypoxia. Consistently, we
found that down-regulation of hnRNP-A2/B1 by RNAi in
hypoxia further decreased hASH1 expression revealing a syn-
ergistic effect that may serve to exacerbate the hypoxic influ-
ence on ASCL1/hASH1 levels. In keeping with this finding,
forced expression of hnRNP-B1 prevented the decrease in
hASH1 levels in hypoxia. Such complex patterns of regulation
call for the existence of common structural elements in target
mRNAs. Interestingly in this regard, a recent study utilized
genome-wide mRNA stability data and identified structural
elements that could play major roles in global mRNA regula-
tion. Using one such structuralmotif foundwithin the 3-UTRs
of transcripts, they identified hnRNP-A2/B1 as a functional
regulator that binds this motif and regulates mRNA stability
(58). Our UV cross-linking experiments indicate that hnRNP-
A2/B1 directly interacts with a GA-rich element in the 5-UTR
ofASCL1mRNA and promotes mRNA stability. It is likely that
binding of hnRNP-A2/B1 at the 5-UTR influences ASCL1
mRNA stability via cross-talk with the 3-UTR. One possible
scenario how hnRNP-A2/B1 might act via the ASCL1 mRNA
3-UTR is through its influence on hnRNP-R expression.
The RBP hnRNP-R represents another ASCL1 mRNA UTR
trans-acting factor identified in this study. hnRNP-R has80%
homology with hnRNP-Q proteins and both have been identi-
fied as components of mRNA granules transported in neuronal
dendrites (59). hnRNP-R has been shown to enhance transcrip-
tion from the c-fos promoter and regulate c-fosmRNAby inter-
acting with an AU-rich element (60, 61).
We identified hnRNP-R to bind to both the 5- and 3-UTR
of ASCL1 mRNA, with stronger binding to the 3-UTR in
hypoxia. Importantly, both factors, hnRNP-A2/B1 and
hnRNP-R, are regulators of hASH1 synthesis. Therefore, we
cannot exclude the possibility that the presence of hnRNP-
A2/B1 influences the binding of hnRNP-R and vice versa. It is of
interest that the shift in binding to the 3-UTR is seen in
hypoxia when hnRNP-A2/B1 levels decline. Moreover, a
knockdown of hnRNP-A2/B1 was associated with a drop in
hnRNP-R mRNA levels and vice versa, suggesting that the net
effect on ASCL1/hASH1 expression is a result of a combined
influence by hnRNP-A2/B1 and hnRNP-R. Collectively, these
data indicate that both hnRNP-A2/B1 and hnRNP-R are
involved in the post-transcriptional regulation of ASCL1/
hASH1 expression in hypoxia. However, the profound effect
the knockdown of hnRNP-A2/B1 had on ASCL1/hASH1 levels
indicate that it is the dominant factor in its regulation. We
cannot exclude the possibility that other trans-acting factors
may exist that act in a cell-type/context-dependentmanner and
together exert a concerted influence on hASH1 synthesis.
The regulatory cues leading to ASCL1/hASH1 down-regula-
tion during development and differentiation are not known.
Because minor changes in its expression can potentially have a
strong impact on its function, any regulatorymechanismaffect-
ing ASCL1/hASH1 levels will be of importance. Using hypoxia
as an experimental means to modulate hASH1 levels, we iden-
tified novel post-transcriptional mechanisms involved in the
regulation of hASH1. Whether such mechanisms are func-
tional in tumor development and differentiation remain to be
determined. In fact, the specific effect of hnRNP-A2/B1 on
ASCL1/hASH1 can be exploited to define the function of
hASH1 during differentiation.
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